查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726283

全球退伍軍人菌檢測市場：市場規模、佔有率、趨勢分析（按類型、最終用途和地區）、細分市場預測（2025-2030 年）

Legionella Testing Market Size, Share, & Trends Analysis Report By Type (Water Testing, IVD Testing), By End Use (Microbial Culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

退伍軍人菌檢測市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球退伍軍人菌檢測市場預計到 2030 年將達到 5.474 億美元，2025 年至 2030 年的複合年成長率為 8.2%。

龐蒂亞克熱和肺炎等退伍退伍軍人菌病發病率的增加是推動市場成長的主要因素之一。根據世界衛生組織 (WHO) 的數據，歐洲、澳洲和美國每年每百萬人有 10 至 15 例新病例。

及時進行退伍軍人菌檢測的趨勢日益成長，這是因為這樣做可以帶來諸如更快康復和改善患者預後等好處。此外，退伍軍人菌檢測與 PCR 和就地檢驗等先進診斷技術的結合預計將在預測期內推動該市場的成長。

預計，退伍軍人菌檢測計畫、宣傳宣傳活動和水安全法規等政府主導的措施將增加全球退伍軍人菌病例的檢測和管理。例如，在歐洲，嚴格的法規要求定期對水系統進行退伍軍人菌檢測，預計將推動對先進退伍軍人菌檢測方法的需求。

退伍軍人菌檢測市場：概述

  • 2024 年，歐洲佔據全球退伍軍人菌檢測市場的主導地位，佔有 39.0% 以上的佔有率，這歸因於人們對 退伍軍人症桿菌檢測市場的主導地位，佔有 39.0% 以上的佔有率，這歸因於人們對退伍軍人菌的認知不斷提高、醫療保健系統日趨完善、公共衛生保護舉措以及英國和德國等國家的強制性檢測規定等因素。
  • 預計預測期內 IVD 測試領域將以顯著的複合年成長率成長。
  • 根據最終用途，PCR 部分將在 2024 年佔據市場主導地位，收入佔有率為 37.7%。 PCR 因其高靈敏度和快速處理時間而可以準確、快速地檢測細菌。
  • 人口、環境和其他因素導致許多地區退伍軍人菌疫情增加，預計將推動需求。
  • 在預測期內，醫療保健系統的顯著加強、對及時干預的認知的不斷提高以及政府與公共衛生相關的舉措可能會為該行業增加有利的成長機會。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章退伍軍人菌檢測市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 退伍軍人菌檢測市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章退伍軍人菌檢測：按類型估算和趨勢

  • 按類型分類的儀表板
  • 退伍軍人菌檢測市場：依類型進行趨勢分析
  • 全球退伍軍人菌檢測市場規模與趨勢分析（按類型）（2018-2030 年）
  • 水質檢測
    • 市場估計與預測（2018-2030）
  • 體外（IVD）診斷測試
    • 市場估計與預測（2018-2030）

第5章退伍軍人菌檢測市場：依最終用途的估計和趨勢分析

  • 特定於應用程式的儀表板
  • 退伍軍人菌檢測市場：依最終用途進行變異分析
  • 全球退伍軍人菌檢測：按最終用途分類的市場規模和趨勢分析（2018-2030 年）
  • 微生物培養
  • 直接螢光抗體（DFA）染色
  • PCR
  • 其他

第6章退伍軍人菌檢測市場：按地區估計和趨勢分析

  • 區域儀表板
  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 退伍軍人菌檢測市場：關鍵要點、區域
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業熱力圖分析（2024年）
  • 公司簡介
    • Abbott
    • Beckman Coulter, Inc
    • BD
    • Bio-Rad Laboratories, Inc.
    • BIOMERIEUX
    • Eiken Chemical Co., Ltd.
    • Hologic, Inc.
    • Pro Lab Diagnostics Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: GVR-1-68038-372-0

Legionella Testing Market Growth & Trends:

The global legionella testing market size is anticipated to reach USD 547.4 million by 2030 and is expected to experience a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc., the increasing incidence of legionella diseases, such as Pontiac fever and pneumonia, is one of the major factors contributing to the market's growth. According to the World Health Organization (WHO), nearly 10 to 15 new cases per million population are identified every year in Europe, Australia, and the U.S.

The growing inclination towards timely legionella testing can be attributed to advantages such as speedy recovery and improved patient outcome. Additionally, integrating legionella testing methods with advanced diagnostic technologies such as PCR and point-of-care testing are expected to fuel growth of this market in the forecast period.

Government-sponsored initiatives, including legionella testing programs, awareness campaigns, and water safety regulations, are estimated to increase the detection and management of legionella cases globally. For instance, in Europe, stringent regulations mandate regular Legionella testing in water systems, which is expected to boost the demand for advanced Legionella testing methods.

Legionella Testing Market Report Highlights:

  • Europe dominated the global legionella testing market with over 39.0% share in 2024 owing to factors such as increasing awareness regarding legionellosis, sophisticated healthcare systems, public health protection initiatives, and mandatory testing regulations in countries such as the UK and Germany.
  • The IVD testing segment is expected to grow at a significant CAGR over the forecast period.
  • Based on end use, the PCR segment dominated market with revenue share of 37.7% in 2024. PCR enables the precise and rapid detection of bacteria through its high sensitivity and quick turnaround time.
  • Increasing legionella outbreaks recorded in numerous regions driven by factors such as demography, environmental factors and others are expected to drive demand.
  • Significantly enhanced healthcare systems, growing awareness regarding timely interventions, and government initiatives associated with public health are likely to add lucrative growth opportunities to this industry over forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional out
  • 2.3. Competitive Insights

Chapter 3. Legionella Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Legionella Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Legionella Testing: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Legionella Testing Market: Type Movement Analysis
  • 4.3. Global Legionella Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Water Testing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. IVD Testing
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Legionella Testing Market: End Use Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Legionella Testing Market: Application Movement Analysis
  • 5.3. Global Legionella Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Microbial culture
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Direct Fluorescent Antibody (DFA) Stain
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. PCR
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Legionella Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Segment Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Legionella Testing market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. U.K.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.K. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.2.5. Key country dynamics
      • 6.5.2.6. Regulatory framework/ reimbursement structure
      • 6.5.2.7. Competitive scenario
      • 6.5.2.8. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Aregentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 1.1.2. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Beckman Coulter, Inc
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. BD
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Bio-Rad Laboratories, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. BIOMERIEUX
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Eiken Chemical Co., Ltd.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Hologic, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Pro Lab Diagnostics Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Takara Bio Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Thermo Fisher Scientific Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Global legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 3. Global legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 5. North America legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 7. North America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 9. U.S. legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Mexico legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 13. Mexico legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Europe legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 16. Europe legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 18. Germany legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19. UK legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 20. UK legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21. France legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 22. France legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Italy legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 24. Italy legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Spain legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 26. Spain legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Denmark legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 28. Denmark legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Sweden legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 30. Sweden legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Norway legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 32. Norway legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 36. China legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 37. China legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Japan legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 39. Japan legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40. India legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 41. India legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 43. South Korea legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Australia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 45. Australia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Thailand legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 47. Thailand legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Latin America legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 50. Latin America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Brazil legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 52. Brazil legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Argentina legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 54. Argentina legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55. MEA legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 56. MEA legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 57. MEA legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 59. South Africa legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 63. UAE legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 65. Kuwait legionella testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Legionella testing market: market outlook
  • Fig. 10 Legionella testing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Legionella testing market driver impact
  • Fig. 16 Legionella testing market restraint impact
  • Fig. 17 Legionella testing market strategic initiatives analysis
  • Fig. 18 Legionella testing market: type movement analysis
  • Fig. 19 Legionella testing market: type outlook and key takeaways
  • Fig. 20 Water testing market estimates and forecast, 2018 - 2030
  • Fig. 21 IVD testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Legionella testing market: End use movement analysis
  • Fig. 23 Legionella testing market: End use outlook and key takeaways
  • Fig. 24 Microbial culture market estimates and forecasts, 2018 - 2030
  • Fig. 25 Direct Fluorescent Antibody (DFA) Stain market estimates and forecasts,2018 - 2030
  • Fig. 26 PCR market estimates and forecasts,2018 - 2030
  • Fig. 27 Others market estimates and forecasts,2018 - 2030
  • Fig. 28 Global Legionella testing market: Regional movement analysis
  • Fig. 29 Global Legionella testing market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 US market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 46 India market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030